Lancashire (LRE) Competitors

Lancashire (LON:LRE) and Mediclinic International (LON:MDC) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.

Do analysts recommend LRE or MDC?

Lancashire presently has a consensus price target of GBX 781, suggesting a potential upside of 25.16%. Given Lancashire's stronger consensus rating and higher possible upside, equities analysts plainly believe Lancashire is more favorable than Mediclinic International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lancashire	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Mediclinic International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the MarketBeat Community prefer LRE or MDC?

Lancashire received 115 more outperform votes than Mediclinic International when rated by MarketBeat users. However, 57.33% of users gave Mediclinic International an outperform vote while only 44.53% of users gave Lancashire an outperform vote.

Company	Underperform	Outperform
Lancashire	Outperform Votes 334 44.53%	Underperform Votes 416 55.47%
Mediclinic International	Outperform Votes 219 57.33%	Underperform Votes 163 42.67%

Is LRE or MDC more profitable?

Lancashire has a net margin of 26.72% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 23.96% beat Mediclinic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lancashire	26.72%	23.96%	6.75%
Mediclinic International	4.99%	5.50%	2.30%

Do insiders and institutionals believe in LRE or MDC?

60.5% of Lancashire shares are held by institutional investors. Comparatively, 39.2% of Mediclinic International shares are held by institutional investors. 0.6% of Lancashire shares are held by company insiders. Comparatively, 48.9% of Mediclinic International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media favor LRE or MDC?

In the previous week, Lancashire had 2 more articles in the media than Mediclinic International. MarketBeat recorded 2 mentions for Lancashire and 0 mentions for Mediclinic International. Lancashire's average media sentiment score of 0.34 beat Mediclinic International's score of 0.00 indicating that Lancashire is being referred to more favorably in the media.

Company	Overall Sentiment
Lancashire	Neutral
Mediclinic International	Neutral

Is LRE or MDC a better dividend stock?

Lancashire pays an annual dividend of GBX 18 per share and has a dividend yield of 2.9%. Mediclinic International pays an annual dividend of GBX 3 per share and has a dividend yield of 0.6%. Lancashire pays out 1,592.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Which has more volatility and risk, LRE or MDC?

Lancashire has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Mediclinic International has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500.

Which has better valuation and earnings, LRE or MDC?

Lancashire has higher earnings, but lower revenue than Mediclinic International. Lancashire is trading at a lower price-to-earnings ratio than Mediclinic International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lancashire	£1.36B	1.10	£363.10M	£1.13	552.21
Mediclinic International	£3.38B	1.09	£169M	£0.23	2,178.26

Summary

Lancashire beats Mediclinic International on 15 of the 20 factors compared between the two stocks.